Abstract
Cabozantinib (CBZ) is a small molecule tyrosine kinase receptor inhibitor, which could also inhibit the ABCG2 transporter function. Therefore, CBZ cou......
小提示:本篇文献需要登录阅读全文,点击跳转登录